Bian, J., Wang, M., Tong, E., Sun, J., Li, M., Miao, Z., . . . Xu, J. (2017). Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation. World J Gastroenterol.
Chicago Style CitationBian, Ji-Lai, Mei-Mei Wang, En-Juan Tong, Jing Sun, Ming Li, Zhi-Bo Miao, Yan-Lin Li, Bai-Hong Zhu, i Jia-Jia Xu. "Benefit of Everolimus in Treatment of an Intrahepatic Cholangiocarcinoma Patient With a PIK3CA Mutation." World J Gastroenterol 2017.
Cita MLABian, Ji-Lai, et al. "Benefit of Everolimus in Treatment of an Intrahepatic Cholangiocarcinoma Patient With a PIK3CA Mutation." World J Gastroenterol 2017.
Atenció: Aquestes cites poden no estar 100% correctes.